Pub Date : 2025-09-01Epub Date: 2025-07-02DOI: 10.1016/j.pbb.2025.174058
Sari Izenwasser
{"title":"Novel insights into kappa and delta opioid receptor function across systems and disorders. Introduction to the special issue","authors":"Sari Izenwasser","doi":"10.1016/j.pbb.2025.174058","DOIUrl":"10.1016/j.pbb.2025.174058","url":null,"abstract":"","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"254 ","pages":"Article 174058"},"PeriodicalIF":3.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144536044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicotine is not only the primary addictive component of smoking but it also greatly contributes to the sensory properties of tobacco. Consequently, investigating the orosensory effects of nicotine is essential to understand the vulnerability to initial stages of cigarette smoking. Within the oral cavity, transient receptor potential vanilloid 1 receptors (TRPV1Rs) are responsible for sensations such as chili peppers-induced pungency and oral burning, and these receptors are activated by nicotine. Here, we hypothesized that TRPV1Rs contribute to the irritant and burning sensations induced by nicotine, and that its dysfunction may promote vulnerability to nicotine addiction. To test this, adult male mice with invalidation of the TRPV1R gene were exposed to oral self-administration of nicotine solution allowing us to examine the key steps of the addictive process, namely acquisition and maintenance of taking behavior, motivation to obtain the drug and nicotine seeking behavior. We found that in comparison to wild-type mice, knockout (KO) mice consumed significantly higher amounts of nicotine both at the training dose and across the dose-response curve. Despite the increased consumption of nicotine by KO mice, this did not promote greater motivational properties of nicotine or cue-induced reinstatement of drug-seeking behavior in the absence of reinforcer. Altogether, these results suggest that decreased function of the TRPV1Rs prevents the development of aversion to nicotine solution, which may contribute to a heightened vulnerability to nicotine initiation.
{"title":"TRPV1 deletion enhances consumption but not seeking behavior for sweetened nicotine solution in male mice","authors":"Salma Tannous, Florence Darlot, Yoan Salafranque, Martine Cador, Stephanie Caille","doi":"10.1016/j.pbb.2025.174054","DOIUrl":"10.1016/j.pbb.2025.174054","url":null,"abstract":"<div><div>Nicotine is not only the primary addictive component of smoking but it also greatly contributes to the sensory properties of tobacco. Consequently, investigating the orosensory effects of nicotine is essential to understand the vulnerability to initial stages of cigarette smoking. Within the oral cavity, transient receptor potential vanilloid 1 receptors (TRPV1Rs) are responsible for sensations such as chili peppers-induced pungency and oral burning, and these receptors are activated by nicotine. Here, we hypothesized that TRPV1Rs contribute to the irritant and burning sensations induced by nicotine, and that its dysfunction may promote vulnerability to nicotine addiction. To test this, adult male mice with invalidation of the TRPV1R gene were exposed to oral self-administration of nicotine solution allowing us to examine the key steps of the addictive process, namely acquisition and maintenance of taking behavior, motivation to obtain the drug and nicotine seeking behavior. We found that in comparison to wild-type mice, knockout (KO) mice consumed significantly higher amounts of nicotine both at the training dose and across the dose-response curve. Despite the increased consumption of nicotine by KO mice, this did not promote greater motivational properties of nicotine or cue-induced reinstatement of drug-seeking behavior in the absence of reinforcer. Altogether, these results suggest that decreased function of the TRPV1Rs prevents the development of aversion to nicotine solution, which may contribute to a heightened vulnerability to nicotine initiation.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"254 ","pages":"Article 174054"},"PeriodicalIF":3.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-06-28DOI: 10.1016/j.pbb.2025.174056
Lee-Yuan Liu-Chen, Peng Huang
Reports in the 1990s and 2000s showed that kappa opioid receptor (KOR) agonists might be promising for treatment and/or prevention of opioid use disorder (OUD) and cocaine use disorder (CUD). However, the side effects associated with KOR agonists available at the time, such as psychotomimesis, dysphoria and sedation, prevented clinical development. Subsequently, nalfurafine and recently triazole 1.1 and oxa-noribogaine, three centrally acting KOR agonists devoid of such side effects, have been studied in animal models of OUD and CUD. By and large, earlier findings with typical KOR agonists were replicated with nalfurafine and in limited studies with triazole 1.1 and oxa-noribogaine. KOR agonists reduced reinforcing effects of mu opioid receptor (MOR) agonists and decreased tolerance to and dependence on MOR agonists. Oxa-noribogaine suppressed cue-induced reinstatement of morphine and fentanyl seeking. KOR agonists countered itch elicited by MOR agonists and produced additive analgesic effects with MOR agonists, thus allowing use of lower doses of MOR and KOR agonists, resulting in lower degrees of MOR-related side effects (such as respiratory depression) and typical KOR-associated side effects. In addition, KOR agonists attenuated locomotor sensitization and conditioned place preference sensitization following repeated cocaine, reduced acquisition and maintenance of cocaine self-administration and decreased cocaine-induced increase in extracellular dopamine. KOR agonists also suppressed cocaine priming-induced reinstatement of cocaine seeking. Therefore, a combination of a KOR agonist and a MOR agonist or a compound with dual KOR/MOR agonist activities when used as analgesics will deter escalation use of MOR agonists, thus prevent OUD, and KOR agonists may be useful for treatment of cocaine abuse and relapse. Importantly, KOR agonists with no or fewer side effects of typical KOR agonists should be further investigated in animal models of OUD and CUD, particularly those that simulate stress-, cue- and drug priming-induced relapse for potential clinical development.
{"title":"KOR agonists for the treatment and/or prevention of opioid use disorder and cocaine use disorder","authors":"Lee-Yuan Liu-Chen, Peng Huang","doi":"10.1016/j.pbb.2025.174056","DOIUrl":"10.1016/j.pbb.2025.174056","url":null,"abstract":"<div><div>Reports in the 1990s and 2000s showed that kappa opioid receptor (KOR) agonists might be promising for treatment and/or prevention of opioid use disorder (OUD) and cocaine use disorder (CUD). However, the side effects associated with KOR agonists available at the time, such as psychotomimesis, dysphoria and sedation, prevented clinical development. Subsequently, nalfurafine and recently triazole 1.1 and oxa-noribogaine, three centrally acting KOR agonists devoid of such side effects, have been studied in animal models of OUD and CUD. By and large, earlier findings with typical KOR agonists were replicated with nalfurafine and in limited studies with triazole 1.1 and oxa-noribogaine. KOR agonists reduced reinforcing effects of mu opioid receptor (MOR) agonists and decreased tolerance to and dependence on MOR agonists. Oxa-noribogaine suppressed cue-induced reinstatement of morphine and fentanyl seeking. KOR agonists countered itch elicited by MOR agonists and produced additive analgesic effects with MOR agonists, thus allowing use of lower doses of MOR and KOR agonists, resulting in lower degrees of MOR-related side effects (such as respiratory depression) and typical KOR-associated side effects. In addition, KOR agonists attenuated locomotor sensitization and conditioned place preference sensitization following repeated cocaine, reduced acquisition and maintenance of cocaine self-administration and decreased cocaine-induced increase in extracellular dopamine. KOR agonists also suppressed cocaine priming-induced reinstatement of cocaine seeking. Therefore, a combination of a KOR agonist and a MOR agonist or a compound with dual KOR/MOR agonist activities when used as analgesics will deter escalation use of MOR agonists, thus prevent OUD, and KOR agonists may be useful for treatment of cocaine abuse and relapse. Importantly, KOR agonists with no or fewer side effects of typical KOR agonists should be further investigated in animal models of OUD and CUD, particularly those that simulate stress-, cue- and drug priming-induced relapse for potential clinical development.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"254 ","pages":"Article 174056"},"PeriodicalIF":3.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-07-04DOI: 10.1016/j.pbb.2025.174059
Daniel Bussinger de Souza Penna , Samara Gumiéro Costa , Marina Pollis Davis , Karin da Costa Calaza , Alexandre dos Santos Rodrigues , Pablo Pandolfo
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by impairments in executive functions, including behavioral inhibition and working memory. The most widely accepted neurobiological explanation for ADHD is related to dopaminergic hypofunction. The dopaminergic system is modulated by endocannabinoid ligands, primarily through the action of cannabinoid receptors type 1 and 2 (CB1R and CB2R) within frontostriatal circuits. Spontaneously hypertensive rats (SHR) are a widely used animal model for studying the neurobiology of ADHD. Our recent study demonstrated that acute treatment with synthetic CB1R and CB2R ligands increased hyperactivity and risk-taking behavior in SHR. We now investigate how chronic modulation of these receptors affects hyperactivity, risk-taking behavior, and working memory assessment in SHR. As expected, the SHR exhibited hyperactivity, difficulties in risk assessment, impaired working memory, and increased risk-taking behavior. Notably, females SHR displayed higher levels of locomotion and risk-taking behavior than their male counterparts, regardless of treatment. Chronic modulation of CB1R and CB2R did not lead to significant changes in any of the evaluated behavioral parameters. Further research is needed to understand both the acute and chronic effects of manipulating cannabinoid receptors and endocannabinoids in the context of ADHD.
{"title":"Chronic modulation of endocannabinoid receptors does not impact hyperactivity, risk behavior, and working memory in an animal model of attention-deficit/hyperactivity disorder","authors":"Daniel Bussinger de Souza Penna , Samara Gumiéro Costa , Marina Pollis Davis , Karin da Costa Calaza , Alexandre dos Santos Rodrigues , Pablo Pandolfo","doi":"10.1016/j.pbb.2025.174059","DOIUrl":"10.1016/j.pbb.2025.174059","url":null,"abstract":"<div><div>Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by impairments in executive functions, including behavioral inhibition and working memory. The most widely accepted neurobiological explanation for ADHD is related to dopaminergic hypofunction. The dopaminergic system is modulated by endocannabinoid ligands, primarily through the action of cannabinoid receptors type 1 and 2 (CB1R and CB2R) within frontostriatal circuits. Spontaneously hypertensive rats (SHR) are a widely used animal model for studying the neurobiology of ADHD. Our recent study demonstrated that acute treatment with synthetic CB1R and CB2R ligands increased hyperactivity and risk-taking behavior in SHR. We now investigate how chronic modulation of these receptors affects hyperactivity, risk-taking behavior, and working memory assessment in SHR. As expected, the SHR exhibited hyperactivity, difficulties in risk assessment, impaired working memory, and increased risk-taking behavior. Notably, females SHR displayed higher levels of locomotion and risk-taking behavior than their male counterparts, regardless of treatment. Chronic modulation of CB1R and CB2R did not lead to significant changes in any of the evaluated behavioral parameters. Further research is needed to understand both the acute and chronic effects of manipulating cannabinoid receptors and endocannabinoids in the context of ADHD.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"254 ","pages":"Article 174059"},"PeriodicalIF":3.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144563821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The current opioid use disorder crisis has been further complicated by the adulteration of the drug supply with the veterinary sedative xylazine. Xylazine is not approved for human use and is associated with numerous adverse effects when consumed. While most existing research has examined the consequences of fentanyl-xylazine co-administration, to date, no studies have explored the behavioral and withdrawal effects of heroin-xylazine co-administration. In the current study, we used a contingent model of heroin-xylazine (0.02 and 0.15 mg/kg/infusion) co-administration to demonstrate that in male rats, heroin consumption and motivation are attenuated when xylazine is co-administered with heroin. However, co-administration with xylazine potentiated cue-induced drug-seeking behavior following 10 days of extinction. In a separate cohort, we evaluated the impact of our selected xylazine dose on locomotion and found that it did not induce sedation, implicating that the behavioral effects produced were not confounded by locomotor suppression. We also assessed naloxone-precipitated withdrawal (1 mg/kg, s.c) and observed a reduction in total somatic withdrawal signs in the heroin-xylazine group, an effect not seen in the heroin-only group. Surprisingly, these reduced somatic signs did not extend to all behavioral modalities and diverged based on the type of somatic signs. These findings suggest that xylazine may function as a satiety-enhancing agent when co-administered with heroin, as evidenced by the suppression of self-administration. However, xylazine's effect on precipitating cue-induced reinstatement reveals the synergistic potential of its adulteration during relapse.
{"title":"Xylazine co-administration influences the rewarding properties of heroin and withdrawal in male rats","authors":"Mason Hochstetler , Anastasia Dodge , Songjukta Chakraborty , Ann Jeffers , Swarup Mitra","doi":"10.1016/j.pbb.2025.174052","DOIUrl":"10.1016/j.pbb.2025.174052","url":null,"abstract":"<div><div>The current opioid use disorder crisis has been further complicated by the adulteration of the drug supply with the veterinary sedative xylazine. Xylazine is not approved for human use and is associated with numerous adverse effects when consumed. While most existing research has examined the consequences of fentanyl-xylazine co-administration, to date, no studies have explored the behavioral and withdrawal effects of heroin-xylazine co-administration. In the current study, we used a contingent model of heroin-xylazine (0.02 and 0.15 mg/kg/infusion) co-administration to demonstrate that in male rats, heroin consumption and motivation are attenuated when xylazine is co-administered with heroin. However, co-administration with xylazine potentiated cue-induced drug-seeking behavior following 10 days of extinction. In a separate cohort, we evaluated the impact of our selected xylazine dose on locomotion and found that it did not induce sedation, implicating that the behavioral effects produced were not confounded by locomotor suppression. We also assessed naloxone-precipitated withdrawal (1 mg/kg, s.c) and observed a reduction in total somatic withdrawal signs in the heroin-xylazine group, an effect not seen in the heroin-only group. Surprisingly, these reduced somatic signs did not extend to all behavioral modalities and diverged based on the type of somatic signs. These findings suggest that xylazine may function as a satiety-enhancing agent when co-administered with heroin, as evidenced by the suppression of self-administration. However, xylazine's effect on precipitating cue-induced reinstatement reveals the synergistic potential of its adulteration during relapse.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"254 ","pages":"Article 174052"},"PeriodicalIF":3.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144286108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-06-14DOI: 10.1016/j.pbb.2025.174053
Julia P. Andreotti , Lia P. Iglesias , Rayssa C. Briânis , Walace C.P. Barra , Igor D.G. Duarte , Cristina A.J. Stern , Leandro J. Bertoglio , José A. Crippa , Daniele C. Aguiar , Fabrício A. Moreira
Conditioned fear is a response to contexts or cues previously paired with aversive stimuli. Substances from the herb Cannabis sativa (phytocannabinoids), such as cannabidiol (CBD), prevent fear responses and hold potential as new treatments for certain psychiatric disorders, such as post-traumatic stress disorder. The phytocannabinoid cannabigerol (CBG), similarly to CBD, lacks psychotomimetic effects and targets multiple receptors involved in fear-related pathways. This study tested the hypothesis that CBG inhibits memory acquisition, consolidation, and retrieval/expression in contextual fear conditioning (CFC) in both male and female C57BL/6 J mice. We also characterized CBG for its activity upon nociceptive and motor responses. Animals were submitted to CFC protocols and CBG (3, 10, or 30 mg/kg) was administered at different timepoints to assess its effect in each memory phase. CBG failed to significantly change the acquisition, consolidation or retrieval/expression of contextual fear memories. Because CFC relies on nociceptive stimuli (shocks), we also evaluated the effects of CBG on the tail-flick test. A biphasic antinociceptive effect occurred 30 min after drug administration in female animals, in which the doses of 3 mg/kg and 30 mg/kg, respectively, increased and reduced the latency for withdrawal response. Finally, no motor impairment was observed in the rotarod test either 30 or 120 min after CBG administration. In summary, CBG (3–30 mg/kg) failed to interfere with CFC in male and female mice, although it induced a biphasic effect on nociceptive response. Future experiments should investigate the role of this substance in different protocols, memory phases, and aversive memory models.
{"title":"Cannabigerol does not affect contextual fear memory in mice but modulates nociception in a sex-dependent manner","authors":"Julia P. Andreotti , Lia P. Iglesias , Rayssa C. Briânis , Walace C.P. Barra , Igor D.G. Duarte , Cristina A.J. Stern , Leandro J. Bertoglio , José A. Crippa , Daniele C. Aguiar , Fabrício A. Moreira","doi":"10.1016/j.pbb.2025.174053","DOIUrl":"10.1016/j.pbb.2025.174053","url":null,"abstract":"<div><div>Conditioned fear is a response to contexts or cues previously paired with aversive stimuli. Substances from the herb <em>Cannabis sativa</em> (phytocannabinoids), such as cannabidiol (CBD), prevent fear responses and hold potential as new treatments for certain psychiatric disorders, such as post-traumatic stress disorder. The phytocannabinoid cannabigerol (CBG), similarly to CBD, lacks psychotomimetic effects and targets multiple receptors involved in fear-related pathways. This study tested the hypothesis that CBG inhibits memory acquisition, consolidation, and retrieval/expression in contextual fear conditioning (CFC) in both male and female C57BL/6 J mice. We also characterized CBG for its activity upon nociceptive and motor responses. Animals were submitted to CFC protocols and CBG (3, 10, or 30 mg/kg) was administered at different timepoints to assess its effect in each memory phase. CBG failed to significantly change the acquisition, consolidation or retrieval/expression of contextual fear memories. Because CFC relies on nociceptive stimuli (shocks), we also evaluated the effects of CBG on the tail-flick test. A biphasic antinociceptive effect occurred 30 min after drug administration in female animals, in which the doses of 3 mg/kg and 30 mg/kg, respectively, increased and reduced the latency for withdrawal response. Finally, no motor impairment was observed in the rotarod test either 30 or 120 min after CBG administration. In summary, CBG (3–30 mg/kg) failed to interfere with CFC in male and female mice, although it induced a biphasic effect on nociceptive response. Future experiments should investigate the role of this substance in different protocols, memory phases, and aversive memory models.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"254 ","pages":"Article 174053"},"PeriodicalIF":3.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144310281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-06-27DOI: 10.1016/j.pbb.2025.174055
Mark D. Namba , Samuel L. Goldberg , Christine M. Side , Abhiram Yadlapalli , Christina M. Curran-Alfaro , Devin Kress , Melissa F. Fogarty , Amanda L.A. Mohr , Jacqueline M. Barker
Cocaine use disorder remains a persistent public health dilemma that currently lacks effective treatment strategies. One key impediment to successful treatment outcomes is increased drug craving that occurs over the course of abstinence and subsequent relapse to drug use. This phenomenon, known as the incubation of drug craving, has been modeled extensively in rodent models of intravenous drug self-administration. The design of most intravenous self-administration studies examining the incubation effect precludes disentangling appetitive and consummatory behaviors as drug seeking (appetitive) and taking (consummatory) is simultaneous. Here, we employed a model of oral cocaine self-administration to interrogate the incubation of drug vs nondrug craving, where the route of administration is identical between reinforcers and appetitive and consummatory behaviors are dissociable. Oral self-administration of cocaine produced detectable levels of cocaine and its metabolite, benzoylecgonine, within the blood and brain, and tissue levels of both substrates correlated with cocaine consumption. When tested for seeking- (lever pressing) and taking-related (magazine head entries) behavior after 1 or 21 days of forced abstinence, we observed incubation of lever pressing among cocaine-administering mice and incubation of magazine entries among saccharin-administering mice. These behavioral changes were accompanied by reduced expression of the glial glutamate transporter GLT-1 within the nucleus accumbens (NAc) of cocaine self-administering mice, regardless of abstinence. Altogether, these results underscore the utility of this model of cocaine self-administration, highlight the conserved nature of incubated cocaine seeking across routes of administration, and demonstrate the dissociable neurobehavioral sequelae of the incubation of reward seeking across reinforcer types.
{"title":"Dissociating the incubation of appetitive and consummatory behavior in a model of oral cocaine self-administration","authors":"Mark D. Namba , Samuel L. Goldberg , Christine M. Side , Abhiram Yadlapalli , Christina M. Curran-Alfaro , Devin Kress , Melissa F. Fogarty , Amanda L.A. Mohr , Jacqueline M. Barker","doi":"10.1016/j.pbb.2025.174055","DOIUrl":"10.1016/j.pbb.2025.174055","url":null,"abstract":"<div><div>Cocaine use disorder remains a persistent public health dilemma that currently lacks effective treatment strategies. One key impediment to successful treatment outcomes is increased drug craving that occurs over the course of abstinence and subsequent relapse to drug use. This phenomenon, known as the incubation of drug craving, has been modeled extensively in rodent models of intravenous drug self-administration. The design of most intravenous self-administration studies examining the incubation effect precludes disentangling appetitive and consummatory behaviors as drug seeking (appetitive) and taking (consummatory) is simultaneous. Here, we employed a model of oral cocaine self-administration to interrogate the incubation of drug vs nondrug craving, where the route of administration is identical between reinforcers and appetitive and consummatory behaviors are dissociable. Oral self-administration of cocaine produced detectable levels of cocaine and its metabolite, benzoylecgonine, within the blood and brain, and tissue levels of both substrates correlated with cocaine consumption. When tested for seeking- (lever pressing) and taking-related (magazine head entries) behavior after 1 or 21 days of forced abstinence, we observed incubation of lever pressing among cocaine-administering mice and incubation of magazine entries among saccharin-administering mice. These behavioral changes were accompanied by reduced expression of the glial glutamate transporter GLT-1 within the nucleus accumbens (NAc) of cocaine self-administering mice, regardless of abstinence. Altogether, these results underscore the utility of this model of cocaine self-administration, highlight the conserved nature of incubated cocaine seeking across routes of administration, and demonstrate the dissociable neurobehavioral sequelae of the incubation of reward seeking across reinforcer types.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"254 ","pages":"Article 174055"},"PeriodicalIF":3.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144514294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01Epub Date: 2025-05-26DOI: 10.1016/j.pbb.2025.174042
Cássio M. Resmim , João V. Borba , Rossano M. Silva , Hevelyn S. Moraes , Camilla W. Pretzel , Julia Canzian , Barbara D. Fontana , Maribel A. Rubin , Eduardo P. Rico , Matthew O. Parker , Denis B. Rosemberg
Alterations in monoamine levels, such as serotonin, play a role in the pathophysiology of affective disorders. Para-chlorophenylalanine (pCPA), a tryptophan hydroxylase inhibitor, impairs serotonin synthesis and increases anxiety-like behaviors in various species. Outbred zebrafish population, such as short fin (SF) and leopard (LEO), differ in serotonin expression, habituation patterns, and responses to novel environments. Locomotor and exploratory profiles are strongly influenced by homebase behavior, which can be assessed in the open field test (OFT). To further investigate a putative role of the serotoninergic system in homebase formation and exploratory behavior dynamics, we administered pCPA to two zebrafish populations (SF and LEO) with distinct anxiety profiles and homebase occupancy. Fish received intraperitoneal injections of pCPA (300 mg/kg) or vehicle for two consecutive days, followed by a 30-min OFT 24 h later. Both pCPA-treated populations showed increased locomotion and periphery occupancy was elevated during the habituation period (first 15 min of testing). Although pCPA did not alter homebase-related behaviors in LEO, the SF population exhibited a delayed homebase formation, likely due to disrupted exploratory-related mechanisms. Furthermore, Principal Component Analysis (PCA) and K-means clustering revealed that behaviors related to periphery occupancy and distance traveled accounted for approximately 80 % of the observed data variability. Collectively, our data show that pCPA impairs homebase formation, with stronger effects in SF fish and increases thigmotaxis. Overall, these results suggest that pCPA disrupts the organization of exploratory behavior, particularly the habituation processes, probably associated with anxiety-like phenotypes.
{"title":"Population-dependent impacts of para-chlorophenylalanine, a tryptophan hydroxylase inhibitor, on homebase formation and thigmotaxis in adult zebrafish","authors":"Cássio M. Resmim , João V. Borba , Rossano M. Silva , Hevelyn S. Moraes , Camilla W. Pretzel , Julia Canzian , Barbara D. Fontana , Maribel A. Rubin , Eduardo P. Rico , Matthew O. Parker , Denis B. Rosemberg","doi":"10.1016/j.pbb.2025.174042","DOIUrl":"10.1016/j.pbb.2025.174042","url":null,"abstract":"<div><div>Alterations in monoamine levels, such as serotonin, play a role in the pathophysiology of affective disorders. Para-chlorophenylalanine (pCPA), a tryptophan hydroxylase inhibitor, impairs serotonin synthesis and increases anxiety-like behaviors in various species. Outbred zebrafish population, such as short fin (SF) and leopard (LEO), differ in serotonin expression, habituation patterns, and responses to novel environments. Locomotor and exploratory profiles are strongly influenced by homebase behavior, which can be assessed in the open field test (OFT). To further investigate a putative role of the serotoninergic system in homebase formation and exploratory behavior dynamics, we administered pCPA to two zebrafish populations (SF and LEO) with distinct anxiety profiles and homebase occupancy. Fish received intraperitoneal injections of pCPA (300 mg/kg) or vehicle for two consecutive days, followed by a 30-min OFT 24 h later. Both pCPA-treated populations showed increased locomotion and periphery occupancy was elevated during the habituation period (first 15 min of testing). Although pCPA did not alter homebase-related behaviors in LEO, the SF population exhibited a delayed homebase formation, likely due to disrupted exploratory-related mechanisms. Furthermore, Principal Component Analysis (PCA) and K-means clustering revealed that behaviors related to periphery occupancy and distance traveled accounted for approximately 80 % of the observed data variability. Collectively, our data show that pCPA impairs homebase formation, with stronger effects in SF fish and increases thigmotaxis. Overall, these results suggest that pCPA disrupts the organization of exploratory behavior, particularly the habituation processes, probably associated with anxiety-like phenotypes.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"253 ","pages":"Article 174042"},"PeriodicalIF":3.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144155179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Although the use of antidepressants during pregnancy has increased over the last several decades, their safety has remained a topic of debate. Selective serotonin reuptake inhibitors (SSRIs) can cross the placenta and affect perinatal outcomes in infants exposed during pregnancy. Recent studies suggest new risks for not only for structural malformations, but also long-term behavioral, developmental, and emotional disorders in offspring.
Aim
We aimed to elucidate the effects by which in utero paroxetine exposure may affect the behavior and hippocampus of the offspring of paroxetine-treated rodent mothers.
Methods
Paroxetine was administered daily to pregnant female Wistar rats from embryonic day (ED) 12.5 to ED 21 with oral sondes. Paroxetine 1 mg/kg/day or paroxetine 2.5 mg/kg/day or saline was given to the control group. We evaluated spontaneous locomotor activity, spontaneous alternation behavior using the Y-maze test, and anxiety behavior using the elevated plus maze (EPM) in male offspring at postnatal day 30. Bromodeoxyuridine (BrdU)-positive cells in the hippocampus were counted using a fluorescence microscope.
Results
Locomotor activities significantly increased in the paroxetine 2.5 mg compared with the control group. The paroxetine 2.5 mg group spent less time in the closed arm than did the control and paroxetine 1 mg groups in the EPM. The number of BrdU-positive cells in the dentate gyrus was significantly increased in the paroxetine 2.5 mg compared with the control group.
Conclusions
These findings suggest that oral administration of paroxetine during pregnancy induces hyperactivity, decreases anxiety, and increases cell proliferation in the hippocampus of male offspring.
{"title":"Administration of paroxetine during pregnancy affects behavioral changes and hippocampal cell proliferation in male offspring in rats","authors":"Junko Horie , Tomoya Kinjo , Masanobu Ito , Toshihito Suzuki","doi":"10.1016/j.pbb.2025.174041","DOIUrl":"10.1016/j.pbb.2025.174041","url":null,"abstract":"<div><h3>Background</h3><div>Although the use of antidepressants during pregnancy has increased over the last several decades, their safety has remained a topic of debate. Selective serotonin reuptake inhibitors (SSRIs) can cross the placenta and affect perinatal outcomes in infants exposed during pregnancy. Recent studies suggest new risks for not only for structural malformations, but also long-term behavioral, developmental, and emotional disorders in offspring.</div></div><div><h3>Aim</h3><div>We aimed to elucidate the effects by which in utero paroxetine exposure may affect the behavior and hippocampus of the offspring of paroxetine-treated rodent mothers.</div></div><div><h3>Methods</h3><div>Paroxetine was administered daily to pregnant female Wistar rats from embryonic day (ED) 12.5 to ED 21 with oral sondes. Paroxetine 1 mg/kg/day or paroxetine 2.5 mg/kg/day or saline was given to the control group. We evaluated spontaneous locomotor activity, spontaneous alternation behavior using the Y-maze test, and anxiety behavior using the elevated plus maze (EPM) in male offspring at postnatal day 30. Bromodeoxyuridine (BrdU)-positive cells in the hippocampus were counted using a fluorescence microscope.</div></div><div><h3>Results</h3><div>Locomotor activities significantly increased in the paroxetine 2.5 mg compared with the control group. The paroxetine 2.5 mg group spent less time in the closed arm than did the control and paroxetine 1 mg groups in the EPM. The number of BrdU-positive cells in the dentate gyrus was significantly increased in the paroxetine 2.5 mg compared with the control group.</div></div><div><h3>Conclusions</h3><div>These findings suggest that oral administration of paroxetine during pregnancy induces hyperactivity, decreases anxiety, and increases cell proliferation in the hippocampus of male offspring.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"253 ","pages":"Article 174041"},"PeriodicalIF":3.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144168606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01Epub Date: 2025-05-23DOI: 10.1016/j.pbb.2025.174039
María Ángeles Martínez-Caballero , Claudia Calpe-López , María Pilar García-Pardo , María Carmen Arenas , Jose Enrique de la Rubia Ortí , María Benlloch , Carmen Manzanedo , María Asunción Aguilar
Stressful experiences can have a serious impact on adolescents, as the process of brain maturation, particularly of the prefrontal cortex, takes place during this developmental period. In animal models, male mice exposed to social defeat during early or late adolescence show increased vulnerability to cocaine reward, but this effect has only been studied in late adolescent female mice exposed to Vicarious Intermittent Social Defeat (VISD). The aim of the present study was to investigate the biochemical and behavioural effects of exposure to VISD during early adolescence in female mice. VISD only induced anxiety-like symptoms in the elevated plus maze (EPM) and increased novelty-seeking behaviour in the hole-board test. Furthermore, the behavioural profile of VISD-exposed mice in these tests was associated with their vulnerability or resilience to cocaine reward in adulthood. Female mice that exhibited a higher frequency of entries in the closed arms of the EPM and a lower latency of dips in the hole-board subsequently acquired cocaine-induced conditioned place preference. Thus, exposure of female mice to VISD during early adolescence also induced short-term changes that increased sensitivity to cocaine reward in susceptible individuals.
{"title":"Enhanced novelty-seeking after early adolescent exposure to vicarious social defeat predicts the vulnerability of female mice to cocaine reward","authors":"María Ángeles Martínez-Caballero , Claudia Calpe-López , María Pilar García-Pardo , María Carmen Arenas , Jose Enrique de la Rubia Ortí , María Benlloch , Carmen Manzanedo , María Asunción Aguilar","doi":"10.1016/j.pbb.2025.174039","DOIUrl":"10.1016/j.pbb.2025.174039","url":null,"abstract":"<div><div>Stressful experiences can have a serious impact on adolescents, as the process of brain maturation, particularly of the prefrontal cortex, takes place during this developmental period. In animal models, male mice exposed to social defeat during early or late adolescence show increased vulnerability to cocaine reward, but this effect has only been studied in late adolescent female mice exposed to Vicarious Intermittent Social Defeat (VISD). The aim of the present study was to investigate the biochemical and behavioural effects of exposure to VISD during early adolescence in female mice. VISD only induced anxiety-like symptoms in the elevated plus maze (EPM) and increased novelty-seeking behaviour in the hole-board test. Furthermore, the behavioural profile of VISD-exposed mice in these tests was associated with their vulnerability or resilience to cocaine reward in adulthood. Female mice that exhibited a higher frequency of entries in the closed arms of the EPM and a lower latency of dips in the hole-board subsequently acquired cocaine-induced conditioned place preference. Thus, exposure of female mice to VISD during early adolescence also induced short-term changes that increased sensitivity to cocaine reward in susceptible individuals.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"253 ","pages":"Article 174039"},"PeriodicalIF":3.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}